Delivery Order SPE2DB20D7061-SPE2DB23FSQJ2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20,000 units/mL of the pharmaceutical product PROCRIT. The $4,595.23 contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a Defense agency, and has a firm fixed price pricing type. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,841.54 firm fixed-price delivery order is for the supply of 10,000 units/ml of the medication PROCRIT. This award is not associated with any set-aside program. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procrit 10,000 units/ml vials valued at $5,089.52. This firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,419.36 to AmerisourceBergen Drug Corp for 20,000 units/mL of Procrit (epoetin alfa), a pharmaceutical product used to treat anemia. This competitively awarded, firm fixed-price delivery order is set to be completed by December 17, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The company's corporate office in Conshohocken, Pennsylvania serves as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,205.34 firm-fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of October 22, 2024....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide a wide range of medical supplies and prescription drugs to the Department of Defense (DoD) and other government agencies. The contract, valued at up to $4,835.97, is a delivery order with a firm fixed-price pricing type. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order contract worth $1,009.94 for the supply of medical vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB23FSQJ2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of PROCRIT 10,000 units/mL vials. The $2,464.38 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This IDC serves as the primary vehicle for Amerisourcebergen to deliver medical commodities to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/7/23 |